ORBIMED ADVISORS LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$10.7B
Holdings
155
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (155 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 6,186,307 | $455.1B | 4255.54% | |
| 2 | EWTXEDGEWISE THERAPEUTICS INC | 13,944,680 | $453.2B | 4237.54% | |
| 3 | PRLDPRELUDE THERAPEUTICS INC | 10,039,691 | $435.0B | 4067.54% | |
| 4 | SPRYSILVERBACK THERAPEUTICS INC | 8,740,887 | $381.4B | 3565.85% | |
| 5 | HZNPHORIZON THERAPEUTICS PUB L | 3,144,355 | $289.4B | 2706.01% | |
| 6 | MRKMERCK & CO. INC | 3,732,400 | $287.7B | 2690.35% | |
| 7 | BMYBRISTOL-MYERS SQUIBB CO | 4,515,400 | $285.1B | 2665.35% | |
| 8 | ABCLABCELLERA BIOLOGICS INC | 8,200,768 | $278.5B | 2604.02% | |
| 9 | BSXBOSTON SCIENTIFIC CORP | 6,920,600 | $267.5B | 2501.01% | |
| 10 | IMAPRELUDE THERAPEUTICS INC | 5,680,186 | $246.1B | 2301.30% | |
| 11 | VRTXVERTEX PHARMACEUTICALS INC | 1,135,900 | $244.1B | 2282.33% | |
| 12 | PMVPPMV PHARMACEUTICALS INC | 7,330,423 | $241.1B | 2254.32% | |
| 13 | —TURNING POINT THERAPEUTICS I | 2,361,327 | $223.4B | 2088.45% | |
| 14 | NTRANATERA INC | 2,195,900 | $223.0B | 2084.84% | |
| 15 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,645,100 | $210.4B | 1967.14% | |
| 16 | MRTXEURMIRATI THERAPEUTICS INC | 1,221,200 | $209.2B | 1955.99% | |
| 17 | ARQTARCUTIS BIOTHERAPEUTICS INC | 6,073,850 | $175.7B | 1642.98% | |
| 18 | IMAIKENA ONCOLOGY INC | 6,215,466 | $175.6B | 1641.78% | |
| 19 | XTNTXTANT MED HLDGS INC | 72,873,494 | $172.0B | 1608.06% | |
| 20 | UNHUNITEDHEALTH GROUP INC | 403,000 | $149.9B | 1402.01% | |
| 21 | GHGUARDANT HEALTH INC | 977,400 | $149.2B | 1395.05% | |
| 22 | HUMHUMANA INC | 313,600 | $131.5B | 1229.34% | |
| 23 | ABBVABBVIE INC | 1,213,200 | $131.3B | 1227.62% | |
| 24 | TBPHTHERAVANCE BIOPHARMA INC | 6,219,110 | $126.9B | 1186.84% | |
| 25 | NBIXNEUROCRINE BIOSCIENCES INC | 1,301,715 | $126.6B | 1183.66% | |
| 26 | PASGPASSAGE BIO INC | 6,962,899 | $121.7B | 1138.03% | |
| 27 | GRCLGRACELL BIOTECHNOLOGIES INC | 7,884,870 | $121.4B | 1135.37% | |
| 28 | —KINNATE BIOPHARMA INC | 3,847,929 | $119.9B | 1121.10% | |
| 29 | DC4DEXCOM INC | 297,400 | $106.9B | 999.38% | |
| 30 | RPTXREPARE THERAPEUTICS INC | 3,426,325 | $105.2B | 983.21% | |
| 31 | KROSKEROS THERAPEUTICS INC | 1,679,417 | $103.4B | 966.51% | |
| 32 | ISRGINTUITIVE SURGICAL INC | 139,600 | $103.2B | 964.53% | |
| 33 | ELVANTHEM INC | 286,600 | $102.9B | 961.90% | |
| 34 | TORCEURADICET BIO INC | 7,232,856 | $94.6B | 884.59% | |
| 35 | HAEHAEMONETICS CORP MASS | 852,000 | $94.6B | 884.35% | |
| 36 | EWEDWARDS LIFESCIENCES CORP | 1,126,400 | $94.2B | 880.90% | |
| 37 | ETNBGBP89BIO INC | 3,729,442 | $88.3B | 825.75% | |
| 38 | PGNYPROGYNY INC | 1,925,260 | $85.7B | 801.25% | |
| 39 | TERNTERNS PHARMACEUTICALS INC | 3,791,204 | $83.4B | 779.87% | |
| 40 | —IKENA ONCOLOGY INC | 2,933,941 | $82.9B | 774.98% | |
| 41 | SYKSTRYKER CORPORATION | 337,400 | $82.2B | 768.44% | |
| 42 | —GEMINI THERAPEUTICS INC | 5,826,224 | $78.9B | 738.15% | |
| 43 | AUPHAURINIA PHARMACEUTICALS INC | 6,069,032 | $78.8B | 736.85% | |
| 44 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,578,174 | $74.0B | 692.09% | |
| 45 | IMGNEURIMMUNOGEN INC | 9,131,822 | $74.0B | 691.62% | |
| 46 | AFIBACUTUS MED INC | 5,477,958 | $73.2B | 684.81% | |
| 47 | SVASINOVAC BIOTECH LTD | 2,839,500 | $72.0B | 673.22% | |
| 48 | CRSPCRISPR THERAPEUTICS AG | 552,500 | $67.3B | 629.48% | |
| 49 | ASNDASCENDIS PHARMA A/S | 505,159 | $65.1B | 608.75% | |
| 50 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,380,900 | $61.9B | 578.97% | |
| 51 | —LOGICBIO THERAPEUTICS INC | 8,466,783 | $61.6B | 576.33% | |
| 52 | MGTXMEIRAGTX HLDGS PLC | 4,102,925 | $59.2B | 553.58% | |
| 53 | MREOMEREO BIOPHARMA GROUP PLC | 17,264,763 | $58.2B | 544.02% | |
| 54 | ORICORIC PHARMACEUTICALS INC | 2,337,574 | $57.3B | 535.50% | |
| 55 | —DECIBEL THERAPEUTICS INC | 4,945,192 | $56.2B | 525.27% | |
| 56 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 5,501,144 | $54.2B | 507.17% | |
| 57 | OSH3EUROAK STR HEALTH INC | 967,000 | $52.5B | 490.69% | |
| 58 | BNRBURNING ROCK BIOTECH LTD | 1,897,663 | $51.1B | 477.66% | |
| 59 | 1T7TRICIDA INC | 9,614,280 | $50.9B | 475.55% | |
| 60 | TMOTHERMO FISHER SCIENTIFIC INC | 110,300 | $50.3B | 470.68% | |
| 61 | ARCTARCTURUS THERAPEUTICS HLDGS | 1,206,886 | $49.8B | 466.05% | |
| 62 | —CURIS INC | 4,366,494 | $49.4B | 462.17% | |
| 63 | —APTOSE BIOSCIENCES INC | 8,030,000 | $48.0B | 448.61% | |
| 64 | —HARPOON THERAPEUTICS INC | 2,285,704 | $47.8B | 447.10% | |
| 65 | CGEMCULLINAN ONCOLOGY INC | 1,146,145 | $47.8B | 446.57% | |
| 66 | VRNAVERONA PHARMA PLC | 5,694,841 | $47.6B | 445.16% | |
| 67 | TELATELA BIO INC | 3,027,542 | $45.1B | 421.79% | |
| 68 | XENEXENON PHARMACEUTICALS INC | 2,497,917 | $44.7B | 418.08% | |
| 69 | APLTAPPLIED THERAPEUTICS INC | 2,257,387 | $42.3B | 395.86% | |
| 70 | CRNXCRINETICS PHARMACEUTICALS IN | 2,753,567 | $42.1B | 393.41% | |
| 71 | SIBNSI BONE INC | 1,305,300 | $41.5B | 388.24% | |
| 72 | NSTGEURNANOSTRING TECHNOLOGIES INC | 622,900 | $40.9B | 382.71% | |
| 73 | ALXNALEXION PHARMACEUTICALS INC | 252,100 | $38.5B | 360.44% | Call |
| 74 | MOHMOLINA HEALTHCARE INC | 162,400 | $38.0B | 354.96% | |
| 75 | KALAKALA PHARMACEUTICALS INC | 5,465,030 | $36.8B | 344.41% | |
| 76 | VORVOR BIOPHARMA INC | 833,333 | $35.9B | 335.83% | |
| 77 | —FUSION PHARMACEUTICALS INC | 3,224,770 | $34.6B | 323.24% | |
| 78 | TREURTRILLIUM THERAPEUTICS INC | 3,166,900 | $34.0B | 318.02% | Call |
| 79 | QUREUNIQURE NV | 969,079 | $32.6B | 305.27% | |
| 80 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,070,955 | $32.6B | 304.37% | |
| 81 | SCPHSCPHARMACEUTICALS INC | 4,797,148 | $31.9B | 298.28% | |
| 82 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 4,015,524 | $31.8B | 297.37% | |
| 83 | —PANDION THERAPEUTICS INC | 528,229 | $31.7B | 296.59% | |
| 84 | —MERSANA THERAPEUTICS INC | 1,892,500 | $30.6B | 286.31% | |
| 85 | —9 METERS BIOPHARMA INC | 25,716,755 | $30.1B | 281.34% | |
| 86 | NVV1NOVAVAX INC | 155,833 | $28.3B | 264.18% | |
| 87 | NXTCNEXTCURE INC | 2,711,013 | $27.1B | 253.74% | |
| 88 | 698ACHILLES THERAPEUTICS PLC | 1,584,845 | $26.2B | 245.25% | |
| 89 | —SIERRA ONCOLOGY INC | 1,477,320 | $25.5B | 238.00% | |
| 90 | GLTOUSDGALECTO INC | 4,090,937 | $24.9B | 232.37% | |
| 91 | CRVSCORVUS PHARMACEUTICALS INC | 8,053,298 | $24.8B | 231.92% | |
| 92 | —GRAYBUG VISION INC | 4,163,347 | $23.1B | 216.06% | |
| 93 | FLBFLUIDIGM CORP DEL | 5,099,571 | $23.1B | 215.52% | Call |
| 94 | —IMARA INC | 2,719,902 | $23.0B | 214.64% | |
| 95 | BIIBBIOGEN INC | 82,000 | $22.9B | 214.49% | |
| 96 | AMGNAMGEN INC | 91,500 | $22.8B | 212.87% | |
| 97 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $22.4B | 209.61% | |
| 98 | CTIC1USDCTI BIOPHARMA CORP | 7,520,600 | $21.9B | 204.63% | |
| 99 | OLMAOLEMA PHARMACEUTICALS INC | 656,126 | $21.8B | 203.55% | |
| 100 | —FLEXION THERAPEUTICS INC | 2,308,083 | $20.7B | 193.15% |
Page 1 of 2Next